NasdaqGS - Delayed Quote USD

Certara, Inc. (CERT)

15.93 -0.28 (-1.73%)
At close: April 19 at 4:00 PM EDT
15.93 0.00 (0.00%)
After hours: April 19 at 4:13 PM EDT
Loading Chart for CERT
DELL
  • Previous Close 16.21
  • Open 16.24
  • Bid 15.90 x 100
  • Ask 15.95 x 100
  • Day's Range 15.83 - 16.32
  • 52 Week Range 11.81 - 24.70
  • Volume 578,031
  • Avg. Volume 553,877
  • Market Cap (intraday) 2.552B
  • Beta (5Y Monthly) 1.63
  • PE Ratio (TTM) --
  • EPS (TTM) -0.35
  • Earnings Date May 7, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 19.72

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

www.certara.com

1,338

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CERT

Performance Overview: CERT

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CERT
9.44%
S&P 500
4.14%

1-Year Return

CERT
34.36%
S&P 500
19.55%

3-Year Return

CERT
43.23%
S&P 500
18.68%

5-Year Return

CERT
--
S&P 500
35.59%

Compare To: CERT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CERT

Valuation Measures

As of 4/20/2024
  • Market Cap

    2.55B

  • Enterprise Value

    2.62B

  • Trailing P/E

    --

  • Forward P/E

    36.23

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.15

  • Price/Book (mrq)

    2.44

  • Enterprise Value/Revenue

    7.39

  • Enterprise Value/EBITDA

    109.89

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -15.62%

  • Return on Assets (ttm)

    0.56%

  • Return on Equity (ttm)

    -5.21%

  • Revenue (ttm)

    354.34M

  • Net Income Avi to Common (ttm)

    -55.36M

  • Diluted EPS (ttm)

    -0.35

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    239.42M

  • Total Debt/Equity (mrq)

    28.90%

  • Levered Free Cash Flow (ttm)

    93.75M

Research Analysis: CERT

Analyst Price Targets

15.50
19.72 Average
15.93 Current
23.00 High
 

Fair Value

Overvalued
% Return
15.93 Current
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Research Reports: CERT

  • Daily – Vickers Top Buyers & Sellers for 11/17/2022

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 08/24/2022

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 08/19/2022

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 08/18/2022

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     

People Also Watch